Optimisation in CT - CT users group

More documents

Recommendations

Info

Effective dose, mSv 30 25 20 15 10 5 0 Liver metastasis, colorectal carcinoma Sequence 4 Sequence 3 Sequence 2 Sequence 1 1 3 5 7 9 11 13 15 17 19 21 Hospital #
European Field Survey Large difference in protocols Large difference in parameters Scanned range No. of series/repeats Tube current Section thickness Great dose reduction potential exists
Page 1 and 2:
A case for shared approach Optimisa
Page 3 and 4: Body CT 2007 Submillimetre sections
Page 5 and 6: Impact of new technique Tasks perfo
Page 7 and 8: Clinical Benefits of MSCT: new appl
Page 9: CT angiography
Page 12 and 13: Clinical benefits of MDCT Multiphas
Page 14 and 15: Acute Appendicitis: effect of incre
Page 16 and 17: Skull Limbs Chest Abdomen IVU Lumba
Page 18 and 19: Mettler at al, 2001 11% of examinat
Page 20 and 21: N o o f p a ts 140 120 100 80 60 40
Page 22 and 23: JRH cases over 1000 mGy-cm Brain 17
Page 25 and 26: Is this the age of imaging over-kil
Page 27 and 28: EC Directive 97/43 Justification Op
Page 29 and 30: Automatic Exposure Control (AEC)
Page 31 and 32: Modifying the examination • Exten
Page 33 and 34: Modifying exposure CT of the chest:
Page 37 and 38: Image quality Im age quality 4.5 4.
Page 39 and 40: New work: Cervical and Lumbar Spine
Page 41 and 42: Fracture Image
Page 43 and 44: Experiment 2: dose reduction in the
Page 46 and 47: 7 6 5 4 3 2 1 0 10 20 30 40 Scores,
Page 48 and 49: Experiment 2: preliminary conclusio
Page 50 and 51: CT working group - 4 th Framework
Page 52 and 53: 14 applications 53 institutions 8 c
Page 56 and 57: 6 th Framework Programme Prospectiv
Page 58 and 59: Justification in Optimisation • E
Page 60 and 61: Delayed diagnosis: ultra-low dose 1
Page 64 and 65: Effective justification Is there a
Page 66: Volume acquisition Acquisition time
Page 72 and 73: The Future More evidence is needed
show all

Optimisation in CT - CT users group

Create successful ePaper yourself

Delete template?

Save as template?